Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. Media Center/
  3. Press releases /
  4. Innovative Medicine

Innovative Medicine

Zytiga® Approved In The European Union For Metastatic Castration-Resistant Prostate Cancer

First once-daily, oral treatment inhibits androgen production at all sources

Young Patients To Benefit From Health Canada Approval Of Remicade®* For Treatment Of Pediatric Ulcerative Colitis

Canadian Children Six To 17 Years Old Become The First Worldwide To Benefit From A New Biologic Treatment Option Approved For Chronic Inflammatory Bowel Disease

Celebrity Chef Sam Talbot Joins “Life First™” Diabetes Awareness Campaign

Talbot Partners With OneTouch® Brand Blood Glucose Monitoring Systems To Help People Learn To Manage Diabetes While Living Life Without Limits

Zytiga™* (Abiraterone Acetate) Receives Health Canada Approval For Treatment Of Metastatic Prostate Cancer

First Oral Treatment for Metastatic Prostate Cancer That Inhibits Androgen Production at All Three Sources

Survey Finds More Than 1 In 3 Americans Have Been Personally Affected By Infections Resulting From A Hospital Stay

Innovative Technology Now Available to Disinfect Healthcare Environment, Helping Protect Patients from Environmental Pathogens